Eton Pharmaceuticals (ETON) earnings, May 14, 2026: EPS +333%, stock +1.0%
In brief
Eton Pharmaceuticals reported on May 14, 2026. Earnings per share changed +333% year over year, 23.5% above the estimate; revenue +40%. The stock opened with a −3.1% gap and closed the day +1.0% (May 15, 2026). The stock is now 29.0% below its 52-week high, +144.9% over 12 months. Next report: Nov 5, 2026.
EPS vs estimate+23.5%
EPS, YoY+333%
Revenue, YoY+40%
Gap · day−3.1% · +1.0%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 14, 2026 | −3.1% | +1.0% |
Next-quarter estimates, ratings and the ETON chart are in the terminal.
Open the terminalFAQ
When is Eton Pharmaceuticals's next earnings report?
Nov 5, 2026. The date comes from daily data and is corrected if the company moves it.
How did Eton Pharmaceuticals stock react to the report?
Opening gap −3.1%, day's result +1.0%.
Did Eton Pharmaceuticals's earnings grow?
Earnings per share rose 333% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.